Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/117073
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Robillard, P.-Y. | - |
dc.contributor.author | Dekker, G. | - |
dc.contributor.author | Chaouat, G. | - |
dc.contributor.author | Scioscia, M. | - |
dc.contributor.author | Iacobelli, S. | - |
dc.contributor.author | Hulsey, T.C. | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | Journal of Reproductive Immunology, 2017; 123:72-77 | - |
dc.identifier.issn | 0165-0378 | - |
dc.identifier.issn | 1872-7603 | - |
dc.identifier.uri | http://hdl.handle.net/2440/117073 | - |
dc.description.abstract | Eclampsia (together with epilepsy) being the first disease ever written down since the beginning of writings in mankind 5000 years ago, we will make a brief presentation of the different major steps in comprehension of Pre-eclampsia. 1) 1840. Rayer, description of proteinuria in eclampsia, 2) 1897 Vaquez, discovery of gestational hypertension in eclamptic women, 3) In the 1970's, description of the "double" trophoblastic invasion existing only in humans (Brosens & Pijnenborg,), 4) between the 1970's and the 1990's, description of preeclampsia being a couple disease. The "paternity problem" (and therefore irruption of immunology), 5) at the end of the 1980's, a major step forward: Preeclampsia being a global endothelial cell disease (glomeruloendotheliosis, hepatic or cerebral endotheliosis, HELLP, eclampsia), inflammation (J.Roberts.C Redman, R Taylor), 6) End of the 1990's: Consensus for a distinction between early onset preeclampsia EOP and late onset LOP (34 weeks gestation), EOP being rather a problem of implantation of the trophoblast (and the placenta), LOP being rather a pre-existing maternal problem (obesity, diabetes, coagulopathies etc…). LOP is predominant everywhere on this planet, but enormously predominant in developed countries: 90% of cases. This feature is very different in countries where women have their first child very young (88% of world births), where the fatal EOP (early onset) occurs in more than 30% of cases. 7) What could be the common factor which could explain the maternal global endotheliosis in EOP and LOP? Discussion about the inositol phospho glycans P type. | - |
dc.description.statementofresponsibility | Pierre-Yves Robillard, Gustaaf Dekker, Gérard Chaouat, Marco Scioscia, Silvia Iacobelli, Thomas C. Hulsey | - |
dc.language.iso | en | - |
dc.publisher | Elsevier | - |
dc.rights | © 2017 Published by Elsevier Ireland Ltd. | - |
dc.source.uri | http://dx.doi.org/10.1016/j.jri.2017.09.006 | - |
dc.subject | Preeclampsia; immunology | - |
dc.title | Historical evolution of ideas on eclampsia/preeclampsia: a proposed optimistic view of preeclampsia | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/j.jri.2017.09.006 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Dekker, G. [0000-0002-7362-6683] | - |
Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.